BI 224436
BI 224436 is a novel HIV-1 noncatalytic site integrase inhibitor with EC50 values of less than 15 nM against different HIV-1 laboratory strains.
Product Specifications
CAS Number
[1155419-89-8]
UNSPSC
12352005
Target
HIV; HIV Integrase
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/BI-224436.html
Purity
99.74
Solubility
DMSO : ≥ 50 mg/mL
Smiles
CC1=C([C@@H](C(O)=O)OC(C)(C)C)[C@@]([C@@]2=CC=C3C4=C2N=CC=C4CCO3)=C5C(C=CC=C5)=N1
Molecular Formula
C27H26N2O4
Molecular Weight
442.51
References & Citations
[1]Fenwick C, et al. Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor. Antimicrob Agents Chemother. 2014 Jun;58 (6) :3233-44.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
HIV-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1208755-01 0.02 mg (E-Coli)
Recombinant Clostridium botulinum Elongation factor P (efp)
Ask
View Details MBS1208755-02 0.1 mg (E-Coli)
Recombinant Clostridium botulinum Elongation factor P (efp)
Ask
View Details MBS1208755-03 0.02 mg (Yeast)
Recombinant Clostridium botulinum Elongation factor P (efp)
Ask
View Details